CD30 in myeloid malignancies: hitting the bull's-eye with an available dart.
作者信息
Emadi Ashkan, Karp Judith E
机构信息
University of Maryland, School of Medicine, Marlene & Stewart Greenebaum Cancer Center, Leukemia & Hematologic Malignancies, Baltimore, MD, USA.
出版信息
Leuk Lymphoma. 2013 Apr;54(4):679-80. doi: 10.3109/10428194.2012.728703. Epub 2012 Sep 28.
PMID:22966972
Abstract
摘要
相似文献
1
CD30 in myeloid malignancies: hitting the bull's-eye with an available dart.
Leuk Lymphoma. 2013 Apr;54(4):679-80. doi: 10.3109/10428194.2012.728703. Epub 2012 Sep 28.
2
CD30 expression in acute myeloid leukemia is associated with FLT3-internal tandem duplication mutation and leukocytosis.
Leuk Lymphoma. 2013 Apr;54(4):860-3. doi: 10.3109/10428194.2012.728596. Epub 2012 Sep 28.
3
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.伴有FLT3突变的急性白血病的生物学特性、临床相关性及分子靶向治疗
Int J Hematol. 2006 May;83(4):301-8. doi: 10.1532/IJH97.06071.
4
"Cup-like" blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML).急性髓系白血病（AML）中的“杯状”原始细胞以及NPM1和FLT3（内部串联重复，ITD）突变
Int J Hematol. 2013 Jul;98(1):3. doi: 10.1007/s12185-013-1371-3. Epub 2013 May 21.
5
6
FLT3 inhibitors for acute myeloid leukemia.用于急性髓系白血病的FLT3抑制剂
Clin Adv Hematol Oncol. 2015 Sep;13(9):573-5.
7
[FLT3 inhibitors for acute myeloid leukemia].用于急性髓系白血病的FLT3抑制剂
Nihon Rinsho. 2014 Jun;72(6):1035-41.
8
Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations.根据世界卫生组织分类标准对174例初发急性髓系白血病进行的前瞻性研究：亚型、细胞遗传学特征及FLT3突变
Eur J Haematol. 2006 Jul;77(1):35-45. doi: 10.1111/j.1600-0609.2006.00660.x. Epub 2006 Mar 27.
9
Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD.伴有FLT3-ITD的急性髓系白血病中CD7的异常表达。
Am J Clin Pathol. 2008 Oct;130(4):644; author reply 645.
10
MSK1 activation in acute myeloid leukemia cells with FLT3 mutations.FLT3 突变的急性髓系白血病细胞中的 MSK1 激活
Leukemia. 2010 May;24(5):1087-90. doi: 10.1038/leu.2010.48. Epub 2010 Apr 1.
Zotero 插件